Harriet Lea-Banks

Lecturer

University College London
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (6)

Year:

2026

Background Perflutren lipid microsphere suspension, sold under the brand name Definity®, is a microbubble ultrasound contrast agent. The microspheres contain octafluoropropane (C 3 F 8 ) gas encapsulated by an outer lipid shell of phospholipids and a polyethylene glycol (PEG)ylated phospholipid. Anaphylaxis to perflutren lipid microsphere is very rare, with only one case report clearly attributing the reaction to the PEG excipient. We report a novel case of anaphylaxis likely caused by a non-PEGylated component of Definity®. Case presentation Our patient is a healthy 54-year-old female, who underwent an exercise stress transthoracic echocardiogram using Definity® as an enhancing agent. She experienced anaphylaxis within 15 min of injection. Symptoms resolved after she was treated with diphenhydramine and epinephrine, followed by a systemic corticosteroid and ondansetron in the Emergency Department. The patient underwent allergy testing at our clinic for Definity® and various PEG-containing substances. While all PEG products tested negative, she had positive intradermal tests to Definity®. She also had negative skin prick testing to PEG 8000 and passed an oral challenge to PEG 3350, thus ruling out PEG as the causative agent of anaphylaxis. Conclusions Our case report highlights a previously undocumented instance of anaphylaxis to Definity® not caused by PEG. We suspect the reaction to be an IgE-mediated response to a non-PEGylated component of Definity®. An alternative explanation for the reaction could be a complement activation-related pseudoallergy. This report provides critical information to physicians on the potential risks of using Definity® and contributes to growing research surrounding the profile of Definity®.

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Takahiro Osada

Associate Professor

Juntendo University

JAPAN
View details

Raag D. Airan

Assistant Professor

Stanford University School of Medicine

UNITED STATES
View details

Miriam Klein-Flugge

University of Oxford

UNITED KINGDOM
View details

Flavia Venetucci Gouveia

Scientist

Hospital for Sick Children

CANADA
View details

Samuel Pichardo

Associate Professor

University of Calgary

CANADA
View details

Kullervo Hynynen

University of Toronto

CANADA
View details